Ref. 1: Compounds, I. of M. (US) P. on D. A. and R.(2000) Vitamin C. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium,and Carotenoids. National Academies Press (US).
Dawodu, A. et al. (2012). Maternal vitamin D status: effect on milk vitamin D content and vitamin D status of breastfeeding infants. Adv. Nutr. 3, 353–361 (2012).
Moretti, D. et al.(2006.) Iron status and foodmatrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. Am. J. Clin. Nutr. 83, 632–638.
Olafsdottir, A. S., et al. (2001). Fat‑solublevitamins in the maternal diet, influence of cod liver oil supplementation and impact of the maternal diet on human milk composition. Ann. Nutr. Metab.45, 265–272 .
Padayatty, S. J. et al. (2003) Vitamin C as anantioxidant: evaluation of its role in disease prevention. J. Am. Coll.Nutr. 22, 18–35 .
Sandström, B. (2001) Micronutrient interactions: effects on absorption and bioavailability. Br. J. Nutr. 85Suppl 2, S181–S185.
Scientific Opinion on Dietary Reference Values for vitamin C | EFSA. EFSA Journal. https://www.efsa.europa.eu/en/efsajournal/pub/3418
Update of the tolerable upper intake level for vitamin D for infants | EFSA. EFSA Journal. https://www.efsa.europa.eu/en/efsajournal/pub/5365
Ref. 2: Akira S., et al. (2006). Pathogen Recognition and Innate Immunity. Cell,124(4), 783–801. doi:10.1016/j.cell.2006.02.015
Akkerman R., et al. (2019). Non-digestible carbohydrates in infant formula as substitution for human milk oligosaccharide functions: Effects on microbiota and gut maturation. Critical Reviews in Food Science and Nutrition, 59(9), 1486–1497. doi:10.1080/10408398.2017.1414030
Alizadeh A., et al. (2016). The piglet as a model for studying dietary components in infant diets: effects of galacto-oligosaccharides on intestinal functions. British Journal of Nutrition, 115(4), 605–618. doi:10.1017/S0007114515004997
Ashley C., et al. (2012). Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial. Nutrition Journal, 11(1), 38. doi:10.1186/1475-2891-11-38
Austin S., et al. (2018). Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula. Molecules,23(10), 2650. doi:10.3390/molecules23102650
Azad M.B., et al. (2018). Human Milk Oligosaccharide Concentrations Are Associated with Multiple Fixed and Modifiable Maternal Characteristics, Environmental Factors, and Feeding Practices. The Journal of Nutrition, 148(11), 1733–1742. doi:10.1093/jn/nxy175
Bai Y., et al. (2018). Fucosylated Human Milk Oligosaccharides and N-Glycans in the Milk of Chinese Mothers Regulate the Gut Microbiome of Their Breast-Fed Infants during Different Lactation Stages. mSystems, 3(6), doi:10.1128/msystems.00206-18
Ben X.M., et al. (2004). Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation interm infants. Chinese Medical Journal, 117(6), 927–931.
Ben X.M., et al. (2008). Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World Journal of Gastroenterology, 14(42), 6564. doi:10.3748/wjg.14.6564
Berger B., et al. (2020). Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics. mBio, 11(2), e03196-19. doi:10.1128/mBio.03196-19
Berger P. K., et al. (2022). Associations of Human Milk Oligosaccharides with Infant Brain Tissue Organization and Regional Blood Flow at 1 Month of Age. Nutrients, 14(18), 3820. doi:10.3390/nu14183820
Bienenstock J., et al.(2013). Fucosylated but Not Sialylated Milk Oligosaccharides Diminish Colon Motor Contractions. PLoSONE, 8(10), e76236. doi:10.1371/journal.pone.0076236
Bode L. (2006). Recent Advances on Structure, Metabolism, and Function of Human Milk Oligosaccharides. The Journal of Nutrition, 136(8),2127–2130. doi:10.1093/jn/136.8.2127
Bode L. (2012). Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology, 22(9),1147–1162. doi:10.1093/glycob/cws074
Bode L., et al. (2016). Overcoming the limited availability of human milk oligosaccharides: challenges and opportunities for research and application . Nutrition Reviews,74(10), 635–644. doi:10.1093/nutrit/nuw025
Bosheva M., et al. (2022). Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial. Frontiers in Nutrition, 9, 920362. doi:10.3389/fnut.2022.920362
Cacho N.T., et al. (2017). Innate Immunity and Breast Milk. Frontiers in Immunology, 8, 584. doi:10.3389/fimmu.2017.00584
Chaturvedi P., et al. (2001). Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology, 11(5), 365–372. doi:10.1093/glycob/11.5.365
Cheng L., et al. (2020). Human Milk Oligosaccharides Differently Modulate Goblet Cells Under Homeostatic, Proinflammatory Conditions and ER Stress. Molecular Nutrition & Food Research, 64(5), 1900976. doi:10.1002/mnfr.201900976
Chichlowski M., et al. (2023). Early development of infant gut microbiota in relation to breastfeeding and human milk oligosaccharides. Frontiersin Nutrition, 10, 1003032. doi:10.3389/fnut.2023.1003032
Chonan O., et al. (1995). Effect of Galactooligosaccharides on Calcium Absorption in Rats. Journal of Nutritional Science and Vitaminology, 41(1), 95–104. doi:10.3177/jnsv.41.95
Chonan O., et al. (1996). The effect of 6’-galactooligosaccharides on bone mineralization of rats adapted to different levels of dietary calcium. International Journal for Vitamin and Nutrition Research, 66(3), 244–249.
Chung H., et al. (2012). Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota. Cell,149(7), 1578–1593. doi:10.1016/j.cell.2012.04.037
Dinleyici M., et al. (2023). Functional effects of human milk oligosaccharides (HMOs). Gut Microbes, 15(1), 2186115. doi:10.1080/19490976.2023.2186115
Donovan S.M., et al. (2016). Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity. Annals of Nutrition and Metabolism, 69(Suppl. 2), 41–51. doi:10.1159/000452818
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the essential composition of infant and follow-on formulae. (o. J.). EFSA Journal,(2014;12(7):3760). doi:10.2903/j.efsa.2014.3760
ESPGHAN Committee on Nutrition; Braegger C., et al.(2011). Supplementation of Infant Formula With Probiotics and/or Prebiotics: A Systematic Review and Comment by the ESPGHAN Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition, 52(2), 238–250. doi:10.1097/MPG.0b013e3181fb9e80
Fallani M., et al. (2010).Intestinal Microbiota of 6‐week‐old Infants Across Europe: Geographic Influence Beyond Delivery Mode,Breast‐feeding, and Antibiotics. Journalof Pediatric Gastroenterology and Nutrition, 51(1), 77–84. doi:10.1097/MPG.0b013e3181d1b11e
Fanaro S., et al. (2009). Galacto-oligosaccharides Are Bifidogenic and Safe at Weaning: A Double-blind Randomized Multicenter Study. Journal of Pediatric Gastroenterology and Nutrition, 48(1), 82–88. doi:10.1097/MPG.0b013e31817b6dd2
Garrido D., et al. (2011). Oligosaccharide Binding Proteins from Bifidobacterium longum subsp. infantis Reveal a Preference for Host Glycans. PLoS ONE, 6(3),e17315. doi:10.1371/journal.pone.0017315
Giovannini M., et al. (2014). Prebiotic Effect of an Infant Formula Supplemented with Galacto-Oligosaccharides: Randomized Multicenter Trial. Journal of the American College of Nutrition, 33(5), 385–393. doi:10.1080/07315724.2013.878232
Goehring K. C., et al. (2016). Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2′-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial. The Journal of Nutrition, 146(12),2559–2566. doi:10.3945/jn.116.236919
González R., et al. (2008). Differential Transcriptional Response of Bifidobacterium longum to Human Milk, Formula Milk, and Galactooligosaccharide. Applied and EnvironmentalMicrobiology, 74(15), 4686–4694. doi:10.1128/AEM.00122-08
Han,S. M., et al. (2020). Do Human Milk Oligosaccharides Protect Against Infant Atopic Disorders and Food Allergy? Nutrients, 12(10),3212. doi:10.3390/nu12103212
He Y., et al. (2014). Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine. Mucosal Immunology, 7(6), 1326–1339. doi:10.1038/mi.2014.20
Hegar B., et al. (2019). The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition. Pediatric Gastroenterology, Hepatology & Nutrition, 22(4), 330. doi:10.5223/pghn.2019.22.4.330
Hill D. R., et al. (2021). Multifunctional Benefits of Prevalent HMOs: Implications for Infant Health. Nutrients, 13(10), 3364. doi:10.3390/nu13103364
Holscher H. D., et al. (2014). Human Milk Oligosaccharides Influence Maturation of Human Intestinal Caco-2Bbe and HT-29 Cell Lines. The Journal of Nutrition, 144(5), 586–591. doi:10.3945/jn.113.189704
Holst A. Q., et al. (2023). Infant Formula Supplemented with Five Human Milk Oligosaccharides Shifts the Fecal Microbiome of Formula-Fed Infants Closer to That of Breastfed Infants. Nutrients, 15(14), 3087. doi:10.3390/nu15143087
Jantscher‑Krenn E., et al. (2012). Human milk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro. British Journal of Nutrition, 108(10), 1839–1846. doi:10.1017/S0007114511007392
Jeurink P. V., et al. (2013). Human milk: a source of more life than we imagine. Beneficial Microbes, 4(1), 17–30. doi:10.3920/BM2012.0040
Kajzer J., et al. (2016). Gastrointestinal Tolerance of Formula Supplemented with Oligosaccharides. The FASEBJournal, 30(S1). doi:10.1096/fasebj.30.1_supplement.671.4
Koletzko B., et al. (2013). Compositional Requirements of Follow-Up Formula for Use in Infancy: Recommendations of an International Expert Group Coordinated by the Early Nutrition Academy. Annals of Nutrition and Metabolism, 62(1),44–54. doi:10.1159/000345906
Kongnum K., et al. (2020). Impacts of Prebiotic-Supplemented Diets and Breastmilk on Population and Diversity of Lactobacilli Established in Thai Healthy Infants. Current Microbiology, 77(7), 1191–1202. doi:10.1007/s00284-020-01920-9
Lin A. E., et al. (2017). Human milk oligosaccharides inhibit growth of group B Streptococcus. Journal of Biological Chemistry, 292(27),11243–11249. doi:10.1074/jbc.M117.789974
Ma L., et al. (2018). Lactational changes in the human milk oligosaccharide concentration in Chinese and Malaysian mothers' milk. International Dairy Journal, 87, 1–10. doi:10.1016/j.idairyj.2018.07.015
Marriage B. J., et al. (2015). Infants Fed a Lower Calorie Formula With 2′FL Show Growth and 2′FL Uptake Like Breast-Fed Infants. Journal of Pediatric Gastroenterology and Nutrition,61(6), 649–658. doi:10.1097/MPG.0000000000000889
Matsuki T., et al. (2016). Infant formula with galacto-oligosaccharides (OM55N) stimulates the growth of indigenous bifidobacteria in healthy term infants. Beneficial Microbes, 7(4), 453–462. doi:10.3920/BM2015.0168
Moukarzel S., et al. (2017). Human Milk Oligosaccharides and the Preterm Infant. Clinics in Perinatology,44(1), 193–207. doi:10.1016/j.clp.2016.11.014
Naarding M. A. (2005). Lewis Xcomponent in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ Tlymphocytes. Journal of Clinical Investigation, 115(11),3256–3264. doi:10.1172/JCI25105
Ottino-González,J., et al. (2024). Consumption of different combinations of human milk oligosaccharides in the first 6 mo of infancy is positively associated with early cognition at 2 y of age in a longitudinal cohort of Latino children. The American Journal of Clinical Nutrition, 120(3), 593–601. doi:10.1016/j.ajcnut.2024.07.020
Paganini D., et al. (2017). Consumption of galacto-oligosaccharides increases iron absorption from a micronutrient powder containing ferrous fumarate and sodium iron EDTA: a stable-isotope study in Kenyan infants. The American Journal of Clinical Nutrition, 106(4), 1020–1031. doi:10.3945/ajcn.116.145060
Paganini D., et al. (2017). Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants. Gut, 66(11), 1956–1967. doi:10.1136/gutjnl-2017-314418
Parschat, K., et al. (2021). Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth. Nutrients, 13(8), 2871. doi:10.3390/nu13082871
Plaza‑Díaz J., et al. (2018). Human Milk Oligosaccharides and Immune System Development. Nutrients, 10(8), 1038. doi:10.3390/nu10081038
Puccio G., et al. (2017). Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. Journal of Pediatric Gastroenterology and Nutrition, 64(4), 624–631. doi:10.1097/MPG.0000000000001520
Reverri E. J., et al. (2018). Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2′-Fucosyllactose. Nutrients, 10(10), 1346. doi:10.3390/nu10101346
Rijnierse A., et al. (2011). Food-derived oligosaccharides exhibit pharmaceutical properties. European Journal of Pharmacology, 668, S117–S123. doi:10.1016/j.ejphar.2011.07.009
Ruiz-Palacios G. M., et al. (2003). Campylobacter jejuni Binds Intestinal H(O) Antigen (Fucα1, 2Galβ1, 4GlcNAc), and Fucosyloligosaccharides of Human Milk Inhibit Its Binding and Infection. Journal of Biological Chemistry, 278(16),14112–14120. doi:10.1074/jbc.M207744200
Santos E. F. D., et al. (2011). Dietary galactooligosaccharides increase calcium absorption in normal and gastrectomized rats. Revista do Colégio Brasileiro de Cirurgiões, 38(3),186–191. doi:10.1590/S0100-69912011000300009
Scholtens P. A. M. J., et al. (2012). The Early Settlers: Intestinal Microbiology in Early Life. Annual Review of Food Science and Technology, 3(1),425–447. doi:10.1146/annurev-food-022811-101120
Shoaf K., et al. (2006). Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichia coli to Tissue Culture Cells. Infection and Immunity, 74(12),6920–6928. doi:10.1128/IAI.01030-06
Sierra C., et al. (2015). Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. European Journal of Nutrition, 54(1),89–99. doi:10.1007/s00394-014-0689-9
Sinclair H. R., et al. (2009). Galactooligosaccharides (GOS) Inhibit Vibrio cholerae Toxin Binding to Its GM1 Receptor. Journal of Agriculturaland Food Chemistry, 57(8), 3113–3119. doi:10.1021/jf8034786
Sjögren Y. M., et al. (2009). Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clinical & Experimental Allergy,39(12), 1842–1851. doi:10.1111/j.1365-2222.2009.03326.x
Smilowitz J. T., et al. (2014). Breast Milk Oligosaccharides: Structure-Function Relationships in the Neonate. Annual Review of Nutrition, 34(1), 143–169. doi:10.1146/annurev-nutr-071813-105721
Stanislawski M. A., et al. (2018). Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort. mBio, 9(5),e01751-18. doi:10.1128/mBio.01751-18
Stewart C. J., et al. (2018). Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature, 562(7728),583–588. doi:10.1038/s41586-018-0617-x
Stiverson J., et al. (2014). Prebiotic Oligosaccharides: Comparative Evaluation Using In Vitro Cultures of Infants' Fecal Microbiomes. Applied and Environmental Microbiology, 80(23), 7388–7397. doi:10.1128/AEM.02200-14
Tanaka M., et al. (2017). Development of the gut microbiota in infancy and its impact on health in later life. Allergology International, 66(4), 515–522. doi:10.1016/j.alit.2017.07.010
Thurl S., et al. (2010). Variation of human milk oligosaccharides in relation to milk groups and lactational periods. British Journal of Nutrition, 104(9), 1261–1271. doi:10.1017/S0007114510002072
Thurl S., et al. (2017). Systematic review of the concentrations of oligosaccharides in human milk. Nutrition Reviews, 75(11), 920–933. doi:10.1093/nutrit/nux044
Urashima T., et al. (2012). The Predominance of Type I Oligosaccharides Is a Feature Specific to Human Breast Milk. Advances in Nutrition, 3(3), 473S-482S. doi:10.3945/an.111.001412
Urashima T., et al. (2018). Human Milk Oligosaccharides as Essential Tools for Basic and Application Studies on Galectins. Trends in Glycoscience and Glycotechnology, 30(172),SE51–SE65. doi:10.4052/tigg.1734.1SE
Vandenplas Y., et al. (2015). Oligosaccharides in infant formula: More evidence tovalidate the role of prebiotics. British Journal of Nutrition, 113(9),1339–1344. doi:10.1017/S0007114515000823
Vandenplas Y., et al. (2018). Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula. Nutrients, 10(9), 1161. doi:10.3390/nu10091161
Vatanen T., et al. (2018). The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature, 562(7728),589–594. doi:10.1038/s41586-018-0620-2
Watson D., et al. (2013). Selective carbohydrate utilization by lactobacilli and bifidobacteria. Journal of Applied Microbiology, 114(4), 1132–1146. doi:10.1111/jam.12105
Weaver C. M., et al. (2011). Galactooligosaccharides Improve Mineral Absorption and Bone Properties in Growing Rats through Gut Fermentation. Journal of Agricultural and Food Chemistry, 59(12), 6501–6510. doi:10.1021/jf2009777
Whisner C. M., et al. (2013). Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: A double-blind cross-over trial. British Journal of Nutrition, 110(7), 1292–1303. doi:10.1017/S000711451300055X
Wiciński M., et al. (2020). Human Milk Oligosaccharides: Health Benefits, Potential Applications in Infant Formulas, and Pharmacology. Nutrients, 12(1), 266. doi:10.3390/nu12010266
Williams T., et al. (2014). Tolerance of Formulas Containing Prebiotics in Healthy, Term Infants. Journal of Pediatric Gastroenterology and Nutrition, 59(5), 653–658. doi:10.1097/MPG.0000000000000513
XuG., et al. (2017). Absolute Quantitation of Human Milk Oligosaccharides Reveals Phenotypic Variations during Lactation. The Journal of Nutrition, 147(1),117–124. doi:10.3945/jn.116.238279
Meeusen E, Cao L, Delsing DJ, et al. Gram-scale chemical synthesis of galactosyllactoses and their impact on infant gut microbiota in vitro. Org Biomol Chem. 2024;22:2091–2097. DOI:10.1039/D3OB02069J.
He Y, Liu S, Leone S, Newburg DS. Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine. Mucosal Immunol. 2014;7(6):1326–1339. DOI: 10.1038/mi.2014.20.
Ayechu-Muruzabal V, van de Kaa M, Mukherjee R,et al. Modulation of the Epithelial-Immune Cell Crosstalk and Related Galectin Secretion by DP3-5 Galacto-Oligosaccharides and β-3′Galactosyllactose. Biomolecules. 2022;12(3):384. DOI:10.3390/biom12030384.
Ref. 3: Yaron S., et al., J Pediatr GastroenterolNutr, 2013 56(4):376-81; Yao M., et al., JPGN, 2014 59 (4):440-448;Hageman J.H.J., et al., International Dairy Journal, 2019 92: 37-49.
Manios Y, Karaglani E, Thijs-Verhoeven I, et al. Effect of milk fat-based infant formulae on stool fatty acid soaps and calcium excretion in healthy term infants: two double-blind randomised cross-over trials. BMCNutrition. 2020;6:46. DOI:10.1186/s40795-020-00365-4.)
Ref. 4: Ambrożej et al. (2021). Milk fat globule membrane supplementation in children: Systematic review with meta-analysis. Nutrients, 13(3), 714. https://doi.org/10.3390/nu13030714.
Thongseiratch et al. (2024). Bovine milk fat globule membrane supplementation and neurocognitive development: A systematic review and meta-analysis. Nutrients,16(14), 2374. https://doi.org/10.3390/nu16142374.
Ref. 5: Forsyth S., et al., Proc Nutr Soc,2017 76(4):568-573.
Ref. 6: Singhal A., et al., Am J Clin Nutr,2008 87(6):1785-1792; Sanchez L.C., et al., Nutritional Neuroscience,2009 12 (1): 2-8
Ref. 7: Zeisel S. H., da Costa K.A., NutritionReviews, 2009 67(11):615-623.
Wu Guoyaou, Amino Acids, 202052:329-360.
European Food Safety Authority, EFSA Journal, 2014 12(7):3760.
